Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Pediatrics
|
June 13, 1998
Factors influencing the spread of pertussis in households
C H Wirsing von König, S Postels-Multani, H Bogaerts, et al.
The Journal of Pediatrics
|
April 1, 1997
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age
H J Schmitt, K Beutel, A Schuind, et al.
European Journal of Pediatrics
|
January 1, 1997
Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine
F Zepp, H J Schmitt, A Kaufhold, et al.
Vaccine
|
February 1, 1991
Development of an acellular pertussis vaccine and its administration as a booster in healthy adults
O Ruuskanen, A Noel, A Putto-Laurila, et al.
European Journal of Pediatrics
|
April 16, 1998
Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations
H J Schmitt, F Zepp, S Müschenborn, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
November 1, 1989
Arbaprostil's [15(R)-15-methyl PGE2] effects on intrauterine pressure in the nonpregnant and pregnant human female--a report of four clinical trials
A R Euler, S Leodolter, J Huber, et al.
Vaccine
|
June 3, 2006
Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life
M Knuf, P Habermehl, J Faber, et al.
The Journal of Infectious Diseases
|
November 1, 1996
Acellular pertussis vaccines: the rationale for an efficacy trial in Germany
H J Schmitt, A Schuind, M Knuf, et al.
The Journal of Pediatrics
|
November 1, 1996
Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants
H J Schmitt, A Schuind, M Knuf, et al.
JAMA
|
January 3, 1996
Efficacy of acellular pertussis vaccine in early childhood after household exposure
H J Schmitt, C H von König, A Neiss, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Pediatrics
|
June 13, 1998
Factors influencing the spread of pertussis in households
C H Wirsing von König, S Postels-Multani, H Bogaerts, et al.
The Journal of Pediatrics
|
April 1, 1997
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age
H J Schmitt, K Beutel, A Schuind, et al.
European Journal of Pediatrics
|
January 1, 1997
Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine
F Zepp, H J Schmitt, A Kaufhold, et al.
Vaccine
|
February 1, 1991
Development of an acellular pertussis vaccine and its administration as a booster in healthy adults
O Ruuskanen, A Noel, A Putto-Laurila, et al.
European Journal of Pediatrics
|
April 16, 1998
Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations
H J Schmitt, F Zepp, S Müschenborn, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
November 1, 1989
Arbaprostil's [15(R)-15-methyl PGE2] effects on intrauterine pressure in the nonpregnant and pregnant human female--a report of four clinical trials
A R Euler, S Leodolter, J Huber, et al.
Vaccine
|
June 3, 2006
Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life
M Knuf, P Habermehl, J Faber, et al.
The Journal of Infectious Diseases
|
November 1, 1996
Acellular pertussis vaccines: the rationale for an efficacy trial in Germany
H J Schmitt, A Schuind, M Knuf, et al.
The Journal of Pediatrics
|
November 1, 1996
Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants
H J Schmitt, A Schuind, M Knuf, et al.
JAMA
|
January 3, 1996
Efficacy of acellular pertussis vaccine in early childhood after household exposure
H J Schmitt, C H von König, A Neiss, et al.
Page
of 4